Suppr超能文献

新型冠状病毒肺炎急性呼吸窘迫综合征体外膜肺氧合治疗后粪肠球菌性脓胸

Enterococcus faecium Empyema Following Extracorporeal Membrane Oxygenation for COVID-19 Acute Respiratory Distress Syndrome.

作者信息

Brown Mark R, Boster Joshua M, Goertzen Stephen M, Morris Michael J, Manninen Erik S

机构信息

Internal Medicine, San Antonio Military Medical Center, San Antonio, USA.

Pulmonary and Critical Care Medicine, San Antonio Military Medical Center, San Antonio, USA.

出版信息

Cureus. 2023 Aug 1;15(8):e42789. doi: 10.7759/cureus.42789. eCollection 2023 Aug.

Abstract

A 33-year-old male with severe COVID-19 required prolonged veno-venous extracorporeal membrane oxygenation (ECMO) support. Following decannulation, he developed an empyema. Tube thoracostomy and broad-spectrum antibiotics were initiated, followed by an unsuccessful attempt at pleural irrigation with saline, given the patient had an increased risk of bleeding due to the concomitant requirement for systemic anticoagulation. Subsequently, intrapleural tissue plasminogen activator (tPA) and recombinant human Dornase alfa (DNase) were safely administered with the resolution of empyema. is an uncommon cause of pleural empyema and, to our knowledge, has not previously been reported to be associated with COVID-19 or ECMO.

摘要

一名33岁的重症新型冠状病毒肺炎男性患者需要长时间的静脉-静脉体外膜肺氧合(ECMO)支持。拔管后,他发生了脓胸。开始进行胸腔闭式引流并使用广谱抗生素,随后尝试用生理盐水进行胸腔冲洗但未成功,因为该患者因同时需要全身抗凝而出血风险增加。随后,胸腔内安全给予组织型纤溶酶原激活剂(tPA)和重组人脱氧核糖核酸酶(DNase),脓胸得以消退。 是胸膜脓胸的罕见原因,据我们所知,此前尚未报道其与新型冠状病毒肺炎或ECMO相关。 (原文此处似乎有信息缺失)

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f54a/10469799/1dfdb495bad1/cureus-0015-00000042789-i01.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验